BioLight Life Sciences Ltd. engages in investing in companies and managing projects in the field of eye diseases and ocular treatments. Its portfolio companies are IOptima Novel Glaucoma Treatment and Micromedic Technologies Ltd. The firm provides each of the subsidiaries with ongoing support, resources and expertise in science, regulation, business development, and intellectual property. IOptima Novel Glaucoma Treatment is engaged in the development, manufacturing and distribution of novel surgical treatments for glaucoma. Micromedic Technologies Ltd focuses, through its investee companies, on the development and commercialization of novel molecular biomarkers related to cancer, including early detection of disease, genetic risk and optimization of treatment modalities.
Follow-Up Questions
Quel est le ratio P/E de Biolight Life Sciences Ltd (BLLSF) ?
Le ratio P/E de Biolight Life Sciences Ltd est de N/A
Quelle est la performance du prix de l'action BLLSF ?
Le prix actuel de BLLSF est de 0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Biolight Life Sciences Ltd ?
Biolight Life Sciences Ltd appartient à l'industrie Life Sciences Tools & Services et le secteur est Health Care
Quelle est la capitalisation boursière de Biolight Life Sciences Ltd ?
La capitalisation boursière actuelle de Biolight Life Sciences Ltd est de $0
Est-ce que Biolight Life Sciences Ltd est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 0 analystes ont établi des notations d'analystes pour Biolight Life Sciences Ltd, y compris 0 achat fort, 0 achat, 0 maintien, 0 vente et 0 vente forte
